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ABSTRACT
Background: Minimal hepatic encephalopathy (MHE) in liver cirrhotic patients is critical manifestation of 
low grade hepatic encephalopaty (HE), is caused quality of life decrease and risk of deteriorating into distinct 
HE. The study was conducted to asses the effect of combination of branched-chain amino acids (BCAA) and 
L-ornithine L-aspartate (LOLA), which was given late evening, on nutritional status and degree of HE.
Method: This single-blind randomized study was conducted on liver cirrhotic outpatients in hepatology 
clinic of Cipto Mangunkusumo Hospital period June 2011-June 2012. The study subjects were divided into two 
groups, group of late evening snack (LS) and day snack (DS). Each group was supplemented with combination 
of milk of BCAAs and LOLA (3.7 g/serving). Evaluation based on history, physical examination, laboratory tests 
and critical flicker frequency (CFF) was performed one month after the intervention. Data were statistically 
analyzed with SPSS 15.
Results: Thirty-two patients whose the inclusion criteria were divided into 16 subjects for each group, LS and 
DS. After one month of the intervention, the average level of prealbumin for DS group was increased statistically 
significant (p < 0.001), but not significant for LS group (p = 0.259). The increase of average body weight,mid-
arm muscle circumference (MAMC) and CFF test result in both groups. There was no improvement on subject 
global assessment (SGA) score after one month intervention in both groups.
Conclusion: This study proved that giving combination of BCAAs and LOLA may improve the condition of 
MHE, however for nutritional status can not be assessed.
Keywords: minimal hepatic encephalopathy, BCAAs, LOLA, prealbumin, SGA score, nutritional status
ABSTRAK
Latar belakang: Ensefalopati hepatikum minimal (EHM) pada pasien sirosis hepatis adalah manifestasi 
ensefalopati hepatikum (EH) derajat ringan yang penting karena mengurangi kualitas hidup dan berisiko jatuh 
ke dalam EH yang nyata. Penelitian ini dilakukan untuk menilai pengaruh pemberian kombinasi asam amino 
rantai cabang (AARC) dan L-ornitin L-aspartat (LOLA) larut malam terhadap status gizi dan derajat EH.
Metode: Penelitian acak tersamar tunggal dilakukan terhadap pasien sirosis hepatis rawat jalan Rumah 
Sakit Cipto Mangunkusumo periode Juni 2011-Juni 2012. Subyek penelitian dibagi dalam dua kelompok yaitu 
kelompok makanan selingan siang hari (MSSH) dan kelompok makanan selingan malam hari (MSMH). Tiap 
kelompok diberikan suplementasi susu kombinasi LOLA dan AARC (3,7 g/saji). Evaluasi berdasarkan anamnesis, 
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pemeriksaan fisik, uji laboratorium dan critical flicker frequency (CFF) dilakukan satu bulan setelah intervensi. 
Data dianalisis secara statistik dengan SPSS 15.
Hasil: Tiga puluh dua pasien yang memenuhi kriteria inklusi terbagi menjadi 16 subyek untuk tiap kelompok, 
MSSH dan MSMH. Setelah 1 bulan intervensi didapatkan peningkatan rerata kadar prealbumin pada kelompok 
MSSH yang signifikan (p < 0,001), namun tidak signifikan pada kelompok MSMH (p = 0,259). Kenaikan rerata 
berat badan, LLA dan hasil CFF yang signifikan ditemukan pada kelompok MSSH dan MSMH. Tidak didapatkan 
perbaikan derajat SGA setelah satu bulan intervensi pada dua kelompok. 
Simpulan: Penelitian ini membuktikan bahwa pemberian kombinasi AARC dan LOLA dapat memperbaiki 
kondisi EHM, namun belum dapat dinilai untuk status gizi. 
Kata kunci: ensefalopati hepatikum minimal, AARC, LOLA, prealbumin, skor SGA, status gizi
INTRODUCTION
Minimal hepatic encephalopathy (MHE) is the 
mildest manifestation of hepatic encephalopathy (HE) 
where there are no any clinical sign of mental disorder, 
yet found by psychometric tests. MHE is important 
because it reduces the quality of life and the risk of 
falling into distinct HE. HE is the one of liver cirrhosis 
complication which has high impact on morbidity 
and mortality. The incidence of HE on liver cirrhosis 
in western countries varies from 30-45% (US) and 
50-70% (UK), where most of them are MHE.1 Asian 
data is also varied, i.e. 62.4% in India, while in the 
outpatient clinic of Cipto Mangunkusumo Hospital 
and Koja Hospital showed that the incidence of MHE 
among the patients with liver cirrhosis were 75.75% 
and 94.4%.2
Liver cirrhosis patients need more protein to 
maintain nitrogen balance compared with healthy 
individuals. This is due to increase of synthesis and 
turn over of protein in patients with liver cirrhosis.3 
Many studies have shown that the nutritional status, 
particularly protein malnutrition condition, determines 
life expectancy of patients with liver cirrhosis. 
Supplementation with branched-chain amino acids 
(BCAAs) and L-ornithine-L-aspartate (LOLA) is 
indicated to improve protein malnutrition. Many 
studies have been conducted to investigate the efficacy 
of therapy BCAA and LOLA separately on nutritional 
status and degree of MHE. These kind of therapy is 
for better in improving the nutritional status, degree 
of MHE and quality of life.
The part of the intervention that has long been 
recommended is routine diet or late evening snack.4 
Late evening snack affects on the energy metabolism 
includes liver cirrhosis-associated metabolic disorder. 
Frequent intake of food in small portions can prevent 
early onset of starvation and also maintain nutritional 
status of liver cirrhosis patients.5 It is believed late 
evening snack can increase the formation of new 
protein, while snack during the day will only be 
used as an energy reserve for the activity.6 This study 
focused on the appropriate time for administration 
the combination of LOLA and BCAAs. BCAAs and 
LOLA combination therapy which had given as snack 
in the late evening were expected to improve the 
nutritional status and the degree of MHE in patients 
with liver cirrhosis measured using modified subjective 
global assessment (SGA) and prealbumin level as 
nutritional status parameters as well as the critical 
flicker frequency (CFF) test result to see improvement 
of hepatic encephalopathy.
METHOD
Upon written approval of the Research Ethics 
Committee of Faculty of Medicine University of 
Indonesia/Cipto Mangunkusumo Hospital, this study 
was conducted between June 2011-June 2012, at 
hepatology outpatient clinic of Cipto Mangunkusumo 
Hospital, Jakarta. Forty adult patients aged over 18 
years who came to the Hepatology outpatient clinic 
of Cipto Mangunkusumo Hospital, which has been 
diagnosed as liver cirrhosis based on supporting data 
from liver biopsy, or meet at least two criterias from 
the typical feature by ultrasonography (USG), the 
existence of esophageal varices, ascites, or increase 
of international ratio (INR), which is not caused by 
another condition5, were included in this study.
Inclusion criteria were based on the consciousness 
level of compost mentis, i.e patients EHM degree 
1 or 2, had value of CFF < 38 Hz, not taking drugs 
that affect liver function (lactulose, LOLA, BCAAs 
and hepato-protector) for one week before treatment, 
patients with impairmentof oral intake and diarrhea, 
pregnancy or lactation, major complications of portal 
hypertension, such as gastrointestinal bleeding, 
hepatorenal syndrome and spontaneous bacterial 
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peritonitis, and hepatoma were excluded in this study.
The sampling method is non-probability consecutive 
sampling. Randomization was undertaken to determine 
the group receiving treatment LS and DS.
All of subjects were given supplementation of milk 
contain with combination of LOLA and BCAAs (3.7 g/
serving). Patients were asked to drink the supplement 
in accordance with the randomization group, i.e DS 
group, time consumption of supplements at 07.30 and 
12.30, while LS group at 21:30 and 07:30, respectively. 
Anamnesis of diet evaluation performed every 2 weeks, 
according to the suggestion of a study conducted by 
Fukushima.7
Analysis of the data distribution was undertaken 
before further statistical analysis. Comparative 
associative hypothesis testing of data with numerical 
scale on dependent group used paired T test for normal 
data distribution and the Wilcoxon test for abnormal 
data distribution, while on independent groups with 
normal data distribution, used unpaired T-test and 
Mann-Whitney U test when the distribution the data 
is abnormal. Chi-square test was used for the ordinal 
scale data analysis. If p < 0.05, then it was considered 
significant. Data from this study were analysed using 
the software SPSS for Windows version 15.0.
RESULT
During the period of June 2011 to February 2012, 
40 cases of liver cirrhosis had met the selection criteria 
recruited for the study subjects. Of the 40 patients 
were then undertaken block randomization, so 20 
patients for each group assigned to the intervention 
snack during the day (DS) and late evening snack 
(LS). A total of 8 patients were excluded from the 
study because of absent on the second visit, financial 
problem and worsening clinical condition. So in the 
end, we collected 32 patients who completed the study 
program, consisting of 16 patients in the DS treatment 
group and 16 patients LS treatment group.
The total number of participant was 32 people, 
consisted of 12 (37.5%) female and 20 (62.5%) male.
The youngest participant in this study was 40 years 
old and the oldest was 77 years of age. The most 
common etiology of liver cirrhosis was hepatitis B, 
22 (68.8%) cases, and hepatitis C 10 (31.3%) cases.
Table 1 summarizes the basic data of patients before 
intervention, while post-intervention results are 
summarized in Table 2.
Comparing the baseline with the post-intervention 
results, there was a significant change of the mean 
prealbumin levels in DS group, but it was not 
statistically significant in LS group (p < 0.001 and p 
= 0.259, respectively).
Table 2. Levels of albumin, SGA, weight, LLA, CFF after intervention
Variables DS group LS group p
Prealbumin level (mg/dL) 10.325 (5.93) 12.146 (6.75) 0.02 *
SGA
Mild (A) 8 (50) 12 (75)
NS **Medium (B) 4 (25) 3 (18.8)
Severe (C) 4 (25) 1 (6.3)
Body weight (kg) 62.45 (12.1) 64.38 (9.4) NS *
Mid-upper arm circumference (cm) 25.53 (3.9) 26.12 (7.3) NS *
Critical flicker frequency 40.04 (4.0) 40.72 (3.7) 0.001 *
DS: day snack; LS: late evening snack; SGA: subjective global assessment; NS: not significant; *Mann-Whitney test; 
**Chi-square test 
Table 1. The baseline characteristics of patients
Variables
The intervention group
DS
Mean (SD)
LS
Mean (SD)
Sex (n/%)
Male
Female
10 (62,5)
6 (37.5%)
10 (62.5)
6 (37.5%)
Age (years) 57.4 (11.0) 57.8 (9.2)
Age group (n/%)
40-60
> 60
9 (56.3)
7 (43.8)
10 (62.5)
6 (37.5)
Body weight (kg) 61.09 (10.9) 60.13 (11.4)
Mid-upper arm circumference 
(cm)
23.503 (3.6) 25.00 (6.8)
Hepatitis (n/%)
B
C
12 (75.0)
4 (25.0)
10 (62.5)
6 (37.5)
Child-Pugh (n/%)
A
B
C
5 (31.3)
9 (56.3)
2 (12.5)
11 (68.8)
5 (31.3)
0
SGA (n/%)
A
B
C
6 (37.5)
8 (50.0)
2 (12.5)
12 (75.0)
3 (18.8)
1 (6.3)
Minimal hepatic 
encephalopathy with CFF 
(Hz)
35.57 (2.1) 35.84 (2.4)
Prealbumin level (mg/dL) 7.105 (3.4) 13.106 (8.3)
Urea nitrogen level (mg/dL) 11.5 (18.3) 14.5 (6.4)
Ureum level (mg/dL) 25.0 (11.2) 28.0 (12.2)
Creatinine level (mg/dL) 0.9 (0.4) 0.8 (0.4)
DS: day snack; LS: late evening snack; SD: standard deviation; MAMC: mid-
upper arm circumference; SGA: subjective global assessment; CFF: critical 
flicker frequency 
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There was an increase of the average body weight in 
the DS and LS group, which was statistically significant 
(p < 0.001). A significant increase of the average 
length of mid-arm muscle circumference (MAMC) 
was found for both groups (p < 0.001 and p = 0.003, 
respectively). The same went on CFF test results, there 
was a significant increase of the average results in both 
groups (p < 0.001 and p = 0.001, respectively).
DISCUSSION
After the nutritional supplementation with BCAAs 
and LOLA for 30 days, the results for nutritional status 
and degree of EH has been obtained. From the total of 
subjects studied, only 16 patients in each group who 
continued the treatment. This was because the subjects 
of the study were taken from outpatients. The difficulty 
found in this study was the patient compliance. Plank 
et al suggested that there are difficulties related 
with patient compliance regarding of supplement 
consumption, especially in outpatients.8
In accordance with the recommendation from 
European Society for Parenteral and Enteral Nutrition 
(ESPEN) 2006, liver cirrhosis patients are suggested to 
get 30-45 kcal/kg/day and protein intake of 1.2-1.5 g/
kg/day. Administer BCAAs enriched-formula (level of 
evidence B) may improve clinical condition, especially 
on the condition of hepatic encephalopathy.9
From the available data, it was known that since 
the beginning of the study, both groups did not have 
the equal basic characteristics prealbumin values, 
this was thought due to the failure of randomization 
because of the relatively small sample size. Thus, the 
interpretation of the results of this study was only based 
on post-treatment prealbumin levels in both groups.
Prealbumin levels improvement were seen in the 
day-time rather than night, this was not consistent 
with the hypothesis of the study. The examination of 
prealbumin level early before the intervention, showed 
the DS 7.105 mg/dL (SD = 3.35) and LS 13.106 mg/dL 
(SD = 8.27). The distribution of prealbumin levels in 
this study was consistent with the Child-Pugh degree. 
In this study, we included the patients who were in the 
state of advanced liver cirrhosis, the Child-Pugh B and 
C, and get the same interventions as other subjects.
Based on the after intervention prealbumin levels 
result, we found an increase in the mean of prealbumin 
level of DS group which was statistically significant, 
p < 0.001. This was predicted because the 
supplementation was consumed by the study 
participants as study instruction. While in the LS 
group, the average level of prealbumin decreased 
after intervention, but not statistically significant (p = 
0.259). Decreased level of prealbumin  in this group 
was thought because blood sampling procedure was 
performed during the day (13:00 to 15:00), where 
the participants of LS group had not received second 
portion of daily supplementation yet, while the 
DS group had received the second portion of daily 
supplementation.
The difference level of prealbumin after the 
intervention was statistically significant between 
groups.It was thought because of short half-life of 
prealbumin, which was 2-3 days, and the interval 
between supplementation and blood sampling schedule 
after intervention were different in both groups. In the 
LS group, the interval between supplementation of 
first portion (07:30) to the second portion (21:30) is 
14 hours, while in the DS group,the interval between 
the supplementation of the first portion (07:30) to the 
second portion (12:30) is 5 hours. In addition, there was 
a great variation in the prealbuminlevel of LS group 
because of one patient who had initial prealbumin 
level far above the average of the 38 mg/dL, who then 
did not perform second sampling (excluded) and then 
considered as outliers.
The decrease average level of prealbumin in this 
study also considered for reliability of examination 
tools and storage process of blood samples. It was 
based on our findings when repeating random check 
by taking a sample of one patient from each group, 
then obtained a different result than the previous 
examinations. Re-examination in one subject from 
DS group after intervention, the result obtained was 
8.9 mg/dL for prealbumin level (initial examination 
10.7 mg/dL). While LS group after intervention, the 
result obtained 8.3 mg/dL for prealbumin level (initial 
examination 8.1 mg/dL). Repeated examination 
was within approximately six months of the initial 
examination. Prealbumin samples were stored in 
freezing temperatures of -800 C in a research laboratory.
Prealbumin, known as thyroxine-binding 
prealbumin or transthyretinis a stable circulating 
glycoprotein synthesized in the liver. Prealbumin 
levels will further decline, along with liver disorder 
from mild state to liver cirrhosis. Hence, prealbumin is 
currently used as one of important prognostic factor in 
liver cirrhosis.10 Serum prealbumin level improvement 
mechanism associated with the administration of 
substitution BCAAs considered as result of improved 
prealbumin turn over. In patients with liver cirrhosis, 
body protein turn over is disturbed, thus the synthesis 
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of prealbumin and albumin become slow, therefore 
BCAAs supplementation may improve this disorder. 
Other studies also suggest that, BCAAs provided direct 
regulatory effect at cellular level, to the sensors of 
leucin intracellular as the molecular target of BCAAs 
in the regulation of protein synthesis and degradation.
In the study by Fukushima et al,7 who observed the 
efficacy of the evening snack administration compared 
to the day in hospitalized patients, concluded that the 
evening snack at 21:00, correlated with high level 
of albumin, particularly at 23:00, where the level of 
albumin could maintain Fischer ratio on physiological 
conditions, especially at night. In present study, it was 
not possible to perform blood test at night, although at 
the end of the intervention was found that prealbumin 
level of LS group was better than DS.
Many studies investigated the effects of the late 
evening snack on the condition of the protein and 
energy malnutrition which was common in patients 
with liver cirrhosis. In a study conducted by Koreeda 
et al, giving substitution BCAAs at night might 
prevent starvation condition overnight and improve 
liver parenchymal cells as the evidence of improved 
nutritional status.11
Increased prealbumin were consistent with other 
studies that investigated the role of BCAAs in 
nutritional status improvement.12 It was also consistent 
to another studies conducted by Muto13 and Nakaya14 
which concluded that there were improvement of 
albumin in patients with liver cirrhosis.
Based on the results of statistical tests on both 
groups DS and LS, showed that, in the DS group 
after intervention hadmore patients with low-grade 
SGA. Meanwhile, in the LS group, the number of 
low-grade SGA did not change significantly after the 
intervention. Based on the basic characteristics of the 
study subjects, it was concluded that both groups could 
not be compared with each other.
In our results, there was no significant improvement 
of SGA scores in both groups. DS and LS. It was 
thought that many factors that influenced the increasing 
of SGA scores, such as albumin and total lymphocytes 
count (TLC). Improvement of these factors were 
difficult to obtain during the short intervention period 
(30 days). In addition, the relatively small sample size, 
might also influence these results.
The average result of CFF after supplementation of 
BCAAs and LOLA significantly increased compared 
with before intervention inboth groups DS and LS, 
p < 0.001 and p = 0.001, respectively. In LS group 
there was no deterioration in CFF result, it indicated 
that the normal protein intake of 1.5 g/kg was safe 
in MHE. CFF which was not deteriorated showed: 
1). The supplementation of normal protein did not 
worsen EH condition, as feared in earlier theories;1,15 
2). Supplementation of nutrition might overcome MHE 
condition in malnourished liver cirrhosis patients. 
Consistent with present study hypothesis, it has shown 
the efficacy of the supplementation of food substitution 
with BCAAs and LOLA was better in LS group 
than DS group, which was statistically significant 
(p < 0.001).
The influence of BCAAs to MHE caused controversy 
in many studies. False neurotransmitter hypothesis 
was originally used as a basic role of BCAA in the 
improvement of HE. It was said that the reduced 
concentration of BCAAs (leucine, isoleucine, and 
valine) and increased aromatic amino acids (AAA; 
phenylalanine, tyrosine, and tryptophan) might 
yieldfalse neurotransmitter that trigger HE.1 Because 
of that, administration of BCAAs-enriched formula 
was initially thought could improve HE.16 However, 
many studies have not been able to prove that BCAAs 
could improve EH.
This present study also proved the efficacy of 
LOLA administration could improve MHE, and the 
administration of LOLA combined with BCAAs 
especially at late evening, is needed to address 
malnutrition in liver cirrhosis. 
In present study, we found several weaknesses. 
For example, a relatively small size of samples that 
likely gave impact on the significance of statistical 
tests result. Additionally, high dropout rate, that was 
thought because this study was done on outpatient. To 
overcame this, we had educated and motivated patients 
routinely and periodically by contacting patients by 
telephone to evaluate complaint, compliance and 
nutritional intake monitoring at home. ESPEN 2006 
recommended the examination of body cell mass 
using bioelectrical impedance analysis (BIA) to assess 
the nutritional status of liver cirrhosis patients. The 
parameter of nutritional status in this study using SGA 
and prealbumin, due to limited funds.
CONCLUSION
The present study showed the significantly increase 
of prealbumin average level for DS group. There was 
also significant increase of average body weight, 
MAMC and CFF test result in both groups. There 
was no improvement on SGA score after 1 month 
intervention in both groups. We concluded that dietary 
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administration 35-40 kcal/kg/day with protein 1.5 g/kg 
with the supplementation of late evening combination 
of BCAAs and LOLA can improve the condition 
of MHE. However, the nutritional status can not be 
assessed, due to the relatively small sample size and the 
present study subjects were from outpatients setting. 
It is considered necessary to conduct further research 
to assess the efficacy supplementation of BCAAs and 
LOLA on the nutritional status and quality of life with 
a larger sample size and better study design.
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